ivermectin

简明释义

英[ˌaɪvəˈmektɪn]美[aɪvərˈmektɪn]

n. 伊佛霉素，伊维除虫菌素

英英释义

单词用法

同义词

反义词

例句

1.They decided to test ivermectin because of what they saw when it was used to treat river blindness in Africa.

科学家们决定对伊维菌素进行测试，是因为当它在非洲被用于治疗河盲症时，他们有所发现。

2.Objective To test the susceptibility of Reticulitermes flaviceps and Coptotermes formosanus workers to ivermectin so as to provide basic information for termite control using ivermectin.

目的 了解台湾乳白蚁和黄胸散白蚁对伊维菌素的敏感性差异，为伊维菌素用于白蚁防制提供依据。

3.Their idea is to dose those in malarious areas with a drug called ivermectin.

他们的方法是让疟疾流行区的人们服用一种名为伊维菌素的药物。

4.These results indicated that the preparation methods of ivermectin nanoemulsion (5%) was simple, and the preparation of ivermectin nanoemulsion was stable and with high safety quality.

结果提示，本研究研制的伊维菌素纳米乳注射液(5%)制备简单，是一种质量稳定、安全性高的新制剂。

5.The finding suggests mass treatment with ivermectin would be a new weapon against malaria, complementing insecticide spraying, bed nets, and other drugs, Foy says.

Foy称，这一发现提示伊佛霉素的大规模治疗可能作为抵抗疟疾的一种新的武器，作为杀虫喷雾剂，蚊帐，以及其他药物的补充。

6.Treatment with ivermectin has enabled significant progress in the control of onchocerciasis, and currently reaches more than 60 million people in Africa annually.

使用伊维菌素使疾病控制取得了明显的进展，非洲目前每年有逾6千万人接受治疗。

7.The compound called ivermectin shortens mosquitoes' life spans and makes them less likely to transmit the malaria parasite.

这种化合物叫做伊维菌素，可以缩短蚊子的寿命，使它们不大可能传播疟原虫。

8.It is important to follow the dosage instructions when using ivermectin for pets.

在给宠物使用ivermectin时，遵循剂量说明是很重要的。

9.Farmers often use ivermectin to control parasites in livestock.

农民经常使用ivermectin来控制牲畜中的寄生虫。

10.The veterinarian prescribed ivermectin for the treatment of parasitic infections in dogs.

兽医开了ivermectin用于治疗狗的寄生虫感染。

11.During the pandemic, some people mistakenly believed that ivermectin could prevent COVID-19.

在疫情期间，一些人错误地认为ivermectin可以预防COVID-19。

12.Clinical trials are being conducted to explore the efficacy of ivermectin against various viral infections.

正在进行临床试验，以探索ivermectin对各种病毒感染的疗效。

作文

In recent years, the drug ivermectin has gained significant attention for its potential uses beyond its original purpose as an antiparasitic medication. Initially developed to treat various parasitic infections in humans and animals, ivermectin has been widely used to combat diseases like river blindness and lymphatic filariasis. Its effectiveness in these areas has made it a crucial tool in public health, especially in tropical regions where such diseases are prevalent.However, the global conversation surrounding ivermectin intensified during the COVID-19 pandemic. Some researchers and healthcare professionals began exploring the possibility of using ivermectin as a treatment for COVID-19, leading to a surge of interest and debate within the scientific community. Proponents argued that ivermectin could inhibit the replication of the virus in vitro, but clinical studies yielded mixed results. As a result, health organizations such as the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) recommended against the use of ivermectin for COVID-19 outside of clinical trials.The controversy surrounding ivermectin highlighted the importance of rigorous scientific research and evidence-based medicine. While the initial excitement about its potential was understandable, it also served as a reminder of the dangers of misinformation and the need for patients to rely on proven treatments. Misinformation can lead to the misuse of medications, which may result in adverse effects or delayed access to effective therapies.Furthermore, the discussion around ivermectin raised broader questions about the pharmaceutical industry and how drugs are marketed to the public. The rapid spread of information—both accurate and inaccurate—on social media platforms during the pandemic showed how quickly opinions could be formed, often without sufficient scientific backing. This phenomenon emphasized the need for critical thinking and skepticism when evaluating new treatments.In addition to its implications for COVID-19, ivermectin continues to play a vital role in treating parasitic infections. The drug's affordability and accessibility have made it a cornerstone of many public health initiatives aimed at eradicating neglected tropical diseases. For example, mass drug administration programs utilizing ivermectin have significantly reduced the incidence of river blindness in several countries, showcasing its impact on global health.In conclusion, ivermectin is a multifaceted drug with a rich history in the fight against parasitic infections. While its potential applications for other diseases, such as COVID-19, have sparked debate, it is essential to approach such discussions with caution and rely on scientific evidence. As we continue to navigate the complexities of modern medicine, ivermectin serves as a reminder of the delicate balance between innovation, research, and responsible healthcare practices. Understanding the proper use and limitations of ivermectin will ensure that it remains a valuable tool in our medical arsenal for years to come.

近年来，药物ivermectin因其超出原始用途的潜在用途而受到广泛关注。最初开发用于治疗人类和动物的各种寄生虫感染，ivermectin被广泛用于对抗河盲症和淋巴丝虫病等疾病。它在这些领域的有效性使其成为公共卫生的重要工具，尤其是在热带地区，这些地区盛行此类疾病。然而，围绕ivermectin的全球讨论在COVID-19大流行期间加剧。一些研究人员和医疗专业人士开始探索将ivermectin作为COVID-19治疗的可能性，导致科学界内的兴趣和辩论激增。支持者认为，ivermectin可以抑制病毒在体外的复制，但临床研究结果却喜忧参半。因此，世界卫生组织（WHO）和美国食品药品监督管理局（FDA）建议不在临床试验之外使用ivermectin治疗COVID-19。围绕ivermectin的争议突显了严格科学研究和循证医学的重要性。尽管对其潜力的初步兴奋是可以理解的，但这也提醒我们注意错误信息的危险，以及患者依赖经过验证的治疗方法的必要性。错误信息可能导致药物的误用，从而可能导致不良反应或延迟获得有效治疗。此外，关于ivermectin的讨论引发了更广泛的问题，即制药行业及药物如何向公众营销。在大流行期间，社交媒体平台上信息（无论准确与否）的快速传播显示了人们形成意见的速度，往往没有足够的科学依据。这一现象强调了在评估新治疗方法时批判性思维和怀疑态度的重要性。除了对COVID-19的影响外，ivermectin继续在治疗寄生虫感染中发挥重要作用。该药物的经济实惠和可获取性使其成为许多公共卫生倡议的基石，旨在根除被忽视的热带疾病。例如，利用ivermectin的大规模药物管理项目显著减少了几个国家河盲症的发生率，展示了其对全球健康的影响。总之，ivermectin是一种多面药物，在对抗寄生虫感染方面拥有丰富的历史。虽然其在其他疾病（如COVID-19）中的潜在应用引发了辩论，但在讨论此类问题时谨慎行事并依赖科学证据至关重要。在继续应对现代医学复杂性的过程中，ivermectin提醒我们在创新、研究和负责任的医疗实践之间保持微妙的平衡。了解ivermectin的正确使用和局限性将确保它在未来数年仍然是我们医疗武器库中的宝贵工具。